Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine‐induced adverse effects in an acute lymphoblastic leukemia patient‐derived xenograft modelHana Starobova, Irina Vetter, Svetlana Shatunova et al.|HemaSphere|2025Cited by 4